The global cutting balloon market, valued at USD 421.2 million in 2023, is projected to experience significant growth over the next decade, with an estimated value of USD 725.9 million by 2033. This growth is being driven by a surge in demand for advanced medical devices, particularly drug-coated cutting balloons, which are expected to maintain a strong market leadership.
In 2022, drug-coated cutting balloons commanded nearly 42.1% of the global market share. These specialized balloons, used primarily in angioplasty procedures to treat narrowed arteries, are gaining increasing traction for their ability to deliver drugs that aid in restenosis prevention and improve patient outcomes. Experts predict that this segment will continue to expand at a compound annual growth rate (CAGR) of over 6.0% from 2023 to 2033.
As a highly effective alternative to traditional angioplasty tools, cutting balloons are revolutionizing interventional cardiology and other medical fields by offering precision and reducing the risk of complications. Their ability to combine cutting technology with drug delivery for improved therapeutic benefits is seen as a major factor in their growing adoption across healthcare facilities worldwide.
The market’s robust outlook reflects both advancements in medical device technology and an increasing demand for minimally invasive treatment options that can ensure higher procedural success rates and shorter recovery times for patients.
Key Takeaways from the Market Study:
- By product, drug-coated cutting balloons accounted for the dominant share in the global cutting balloons market, with a valuation of USD 5 Million in 2022. The drug-coated cutting balloons are set for rapid growth due to direct drug delivery, reduced stent reliance, and validated efficacy for coronary artery disease treatment.
- With a valuation of USD 234.1 Million in 2022, the application in coronary artery disease accounted for a significant portion of the global cutting balloons market. Cutting balloons for the treatment of coronary artery disease uses microsurgical blades to precisely modify plaque, lowering risks and enhancing results.
- Hospitals held the prominent end-user market share in the global cutting balloons market in 2022, growing rapidly with a CAGR of 8% in the predicted period. Hospitals play a pivotal role as key consumers in the global coronary artery disease market, providing essential detection, treatment, and patient care.
- North America maintained the predominant regional position in the global cutting balloons market in 2022, with a revenue share of 2% owed to large patient pool and growing cardiovascular surgical procedures
“Cutting balloons revolutionize coronary care, employing microsurgical precision to mitigate risks and elevate treatment outcomes effectively,” says an analyst of Future Market Insights.
Increased Market Attention: Delve into Detailed Trends and Analysis with Our Report!
Market Competition:
The cutting balloons market is highly competitive. Key manufacturers are constantly innovating and developing novel yet economic product lines to increase their consumer base in emerging regions.
- In May 2021, Philips launched AngioSculpt Evo scoring balloon catheter which is a safe, dilate-resistant option for treating coronary artery stenosis, offering maximum dilation force with less dissection risk compared to other PTCA balloons.
What Does the Report Cover?
Future Market Insights offers a unique perspective and actionable insights on the cutting balloons market in its latest study, presenting a historical demand assessment of 2017 to 2022 and projections for 2023 to 2033. The global cutting balloons market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader
The research study is based on the product (drug-coated cutting balloons, conventional cutting balloons, and scoring balloons), application (coronary artery disease, and peripheral artery disease), and end user (hospitals, cardiac centers, and ambulatory surgical Centers), across 7 key regions of the world.
Key Companies Profiled:
- Abbott
- Boston Scientific Corporation
- B. Braun Melsungen AG
- Cook Medical
- Cordis
- Medtronic
- MicroPort Scientific Corporation
- Opto Circuits (India) Ltd.
- Spectranetics (Philips Healthcare)
- Terumo Corporation
- TriReme Medical, LLC (QT Vascular Ltd.)
- Vascular Concepts Limited
Key Market Segments Covered in the Cutting Balloons Industry Research
By Product:
- Drug-coated
- Conventional
- Scoring
By Application:
- Coronary Artery Disease
- Peripheral Artery Disease
By End User:
- Hospitals
- Cardiac Centers
- Ambulatory Surgical Centers
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
